CatalystFDA/Bio

FDA APPROVED REPLIMUNE'S MELANOMA TREATMENT AFTER REJECTING IT TWICE - QZ

FDA approval after two prior rejections signals significant regulatory shift.

What changed

FDA approval after two prior rejections signals significant regulatory shift.

Why it matters

FDA approval after two prior rejections signals significant regulatory shift. — impact context not separately stored; see What changed.

Sources